Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04906382
Title Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Floor Backes
Indications

uterine carcinosarcoma

endometrial carcinoma

Therapies

Carboplatin + Paclitaxel + Tislelizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST